Yisong Zhen

856 total citations
27 papers, 647 citations indexed

About

Yisong Zhen is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Yisong Zhen has authored 27 papers receiving a total of 647 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 8 papers in Cardiology and Cardiovascular Medicine and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Yisong Zhen's work include Congenital heart defects research (7 papers), Cardiomyopathy and Myosin Studies (4 papers) and Hormonal Regulation and Hypertension (4 papers). Yisong Zhen is often cited by papers focused on Congenital heart defects research (7 papers), Cardiomyopathy and Myosin Studies (4 papers) and Hormonal Regulation and Hypertension (4 papers). Yisong Zhen collaborates with scholars based in China, United States and Thailand. Yisong Zhen's co-authors include Rutai Hui, Yibo Wang, Kai Sun, Weili Zhang, Jingzhou Chen, Yunfeng Han, Yuejin Yang, Xu Yang, Jizheng Wang and Xiaodong Song and has published in prestigious journals such as Circulation, Stroke and Scientific Reports.

In The Last Decade

Yisong Zhen

26 papers receiving 625 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yisong Zhen China 16 282 212 103 65 65 27 647
Channa Zhang China 15 150 0.5× 192 0.9× 61 0.6× 72 1.1× 65 1.0× 38 609
Claudio Flores Chile 13 365 1.3× 155 0.7× 183 1.8× 99 1.5× 44 0.7× 16 1.0k
Kátia Gonçalves dos Santos Brazil 20 316 1.1× 243 1.1× 173 1.7× 67 1.0× 35 0.5× 43 1.0k
Marcel Roos Germany 16 263 0.9× 142 0.7× 76 0.7× 164 2.5× 86 1.3× 38 808
Zeinab Deris Zayeri Iran 11 220 0.8× 141 0.7× 82 0.8× 134 2.1× 33 0.5× 29 720
Hermann Joseph Gröne Germany 8 323 1.1× 84 0.4× 100 1.0× 102 1.6× 54 0.8× 8 863
Vajir Malek India 18 277 1.0× 230 1.1× 147 1.4× 84 1.3× 30 0.5× 28 764
Yafa Naim Abu Nabah Spain 12 152 0.5× 192 0.9× 82 0.8× 67 1.0× 42 0.6× 13 674
Chunpeng Zou China 14 310 1.1× 211 1.0× 80 0.8× 92 1.4× 20 0.3× 35 799
Takeshi Hibino Japan 16 119 0.4× 171 0.8× 151 1.5× 171 2.6× 49 0.8× 39 567

Countries citing papers authored by Yisong Zhen

Since Specialization
Citations

This map shows the geographic impact of Yisong Zhen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yisong Zhen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yisong Zhen more than expected).

Fields of papers citing papers by Yisong Zhen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yisong Zhen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yisong Zhen. The network helps show where Yisong Zhen may publish in the future.

Co-authorship network of co-authors of Yisong Zhen

This figure shows the co-authorship network connecting the top 25 collaborators of Yisong Zhen. A scholar is included among the top collaborators of Yisong Zhen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yisong Zhen. Yisong Zhen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ye, Linying, Wen Zhang, Yisong Zhen, et al.. (2024). AMBRA1 drives gastric cancer progression through regulation of tumor plasticity. Frontiers in Immunology. 15. 1494364–1494364.
2.
Zhou, Bingying, Junwei Liu, Zongna Ren, et al.. (2017). Cnot3 enhances human embryonic cardiomyocyte proliferation by promoting cell cycle inhibitor mRNA degradation. Scientific Reports. 7(1). 1500–1500. 10 indexed citations
3.
Zhen, Yisong. (2016). CardioTF, a database of deconstructing transcriptional circuits in the heart system. PeerJ. 4. e2339–e2339. 1 indexed citations
4.
Zhen, Yisong, Qing Wu, Nannan Chang, et al.. (2012). Overlapping Cardiac Programs in Heart Development and Regeneration. Journal of genetics and genomics. 39(9). 443–449. 10 indexed citations
5.
Zhen, Yisong, et al.. (2011). Recent progress in heart regeneration. Hereditas (Beijing). 33(11). 1159–1163. 1 indexed citations
6.
Chen, Jingzhou, Yi Shi, Ziyu Li, et al.. (2011). A Functional Variant of IC53 Correlates with the Late Onset of Colorectal Cancer. Molecular Medicine. 17(7-8). 607–618. 17 indexed citations
7.
Han, Yunfeng, Xiaohan Fan, Kai Sun, et al.. (2011). Hypertension associated polymorphisms in WNK1/WNK4 are not associated with hydrochlorothiazide response. Clinical Biochemistry. 44(13). 1045–1049. 8 indexed citations
8.
Zhang, Weili, Kai Sun, Yisong Zhen, et al.. (2009). VEGF Receptor-2 Variants Are Associated With Susceptibility to Stroke and Recurrence. Stroke. 40(8). 2720–2726. 42 indexed citations
9.
Yang, Hongjun, Jianxin Chen, Shihuan Tang, et al.. (2009). NEW DRUG R&D OF TRADITIONAL CHINESE MEDICINE: ROLE OF DATA MINING APPROACHES. Journal of Biological Systems. 17(3). 329–347. 29 indexed citations
10.
Wang, Hu, Chen Chen, Xiaodong Song, et al.. (2007). Mef2c is an essential regulatory element required for unique expression of the cardiac‐specific CARK gene. Journal of Cellular and Molecular Medicine. 12(1). 304–315. 19 indexed citations
11.
Fan, Xiaohan, Yibo Wang, Kai Sun, et al.. (2007). Polymorphisms of ACE2 Gene are Associated With Essential Hypertension and Antihypertensive Effects of Captopril in Women. Clinical Pharmacology & Therapeutics. 82(2). 187–196. 82 indexed citations
12.
Zhang, Weili, et al.. (2007). Interaction of Genetic Risk Factors Confers Higher Risk for Thrombotic Stroke in Male Chinese: A Multicenter Case‐Control Study. Annals of Human Genetics. 71(5). 620–629. 24 indexed citations
13.
Zhen, Yisong, Yibo Wang, Weili Zhang, Chunxiao Zhou, & Rutai Hui. (2006). CardioSignal: A database of transcriptional regulation in cardiac development and hypertrophy. International Journal of Cardiology. 116(3). 338–347. 4 indexed citations
14.
Yang, Xu, Yan Gao, Yisong Zhen, et al.. (2005). Plasma homocysteine thiolactone adducts associated with risk of coronary heart disease. Clinica Chimica Acta. 364(1-2). 230–234. 52 indexed citations
15.
Chen, Jingzhou, Yu Han, Chunxia Lin, et al.. (2005). PDGF-D contributes to neointimal hyperplasia in rat model of vessel injury. Biochemical and Biophysical Research Communications. 329(3). 976–983. 33 indexed citations
16.
Wang, Yibo, Yisong Zhen, Yi Shi, et al.. (2005). Vitamin K Epoxide Reductase: A Protein Involved in Angiogenesis. Molecular Cancer Research. 3(6). 317–323. 18 indexed citations
17.
Song, Lei, Yubao Zou, Jizheng Wang, et al.. (2004). Mutations profile in Chinese patients with hypertrophic cardiomyopathy. Clinica Chimica Acta. 351(1-2). 209–216. 53 indexed citations
18.
Teng, Siyong, Lijuan Ma, Yisong Zhen, et al.. (2003). Novel gene hKCNE4 slows the activation of the KCNQ1 channel. Biochemical and Biophysical Research Communications. 303(3). 808–813. 31 indexed citations
19.
Liu, Baohua, Yuqing Liu, Jingzhou Chen, et al.. (2002). CARP is a novel caspase recruitment domain containing pro-apoptotic protein. Biochemical and Biophysical Research Communications. 293(5). 1396–1404. 16 indexed citations
20.
Chen, Jingzhou, Baohua Liu, Yuqing Liu, et al.. (2002). A novel gene IC53 stimulates ECV304 cell proliferation and is upregulated in failing heart. Biochemical and Biophysical Research Communications. 294(1). 161–166. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026